Intelligence · Clinical Pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
- Programs
- 1,839
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
-
epoprostenol
Ultragenyx UK Limited
Hypertension, Pulmonary
1 trial -
fecal microbiota transplantation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ulcerative Colitis
1 trial -
ferric carboxymaltose
Vifor Fresenius Medical Care Renal Pharma France
Iron Deficiency
1 trial -
film dressing by adhesive
Chinese University of Hong Kong
Chronic Peritoneal Dialysis
1 trial -
first-line scheme+compound kushen injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Colorectal Carcinoma
1 trial -
fluocinolone acetonide 190 micrograms
ANI PHARMACEUTICALS INC
Non-infectious Uveitis Affecting the Posterior Segment of the Eye
1 trial -
fluticasone/salmeterol, tiotropium
Hospital Authority, Hong Kong
COPD
1 trial -
formoterol fumarate
Universal Integrated
Pulmonary Disease, Chronic Obstructive
1 trial -
gabapentin + tramadol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pain
1 trial -
gastric scintigraphy
Hospital Authority, Hong Kong
Functional Dyspepsia
1 trial -
ginkgolide
The First People's Hospital of Lianyungang
Intravenous Alteplase Thrombolysis
1 trial -
glargine + exenatide
Hong Kong Baptist University
Type 2 Diabetes Mellitus
1 trial -
glatiramer acetate
Teva Pharma GmbH
Multiple Sclerosis
2 trials -
glatiramer acetate injection with oral cetirizine hydrochloride
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
half-dose ticagrelor
The First People's Hospital of Lianyungang
Acute Coronary Syndrome
1 trial -
handwashing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Communicable Diseases
1 trial -
hepatitis B vaccine made by Recombinant DNA Techniques in Saccharomyces Cerevisiae
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis B Vaccines
1 trial -
hyaluronic Acid + platelet-rich plasma
Regeneron Ireland Designated Activity Company (DAC)
Knee Osteoarthritis
1 trial -
hyaluronidase (human recombinant)/rehydration fluid
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
hydrochloride hydromorphone + flurbiprofen axetil
The First People's Hospital of Lianyungang
Enhanced Recovery After Surgery
1 trial -
hydroxyethl starch
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cesarean Section
1 trial -
hylan G-F 20
United Therapeutics Europe Ltd
Osteoarthritis, Knee
1 trial -
hylenex-facilitated subcutaneous Lactated Ringer's infusion
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
ibandronate [Bonviva/Boniva]
Hoffmann-La Roche
Post Menopausal Osteoporosis
1 trial -
iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Bipolar Disorder
1 trial -
imiquimod
United Therapeutics Europe Ltd
Anal Dysplasia
1 trial -
imiquimod 5% cream
RIGEL PHARMACEUTICALS INC
Actinic Keratoses
1 trial -
immunoglobulin G
Green Valley (Shanghai) Pharmaceuticals Co.,
Kawasaki Disease
1 trial -
inactivated EV71 vaccine (KMB-17 cells)
Chinese University of Hong Kong
Hand, Foot and Mouth Disease (HFMD)
1 trial -
inhaled treprostinil
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
3 trials -
inotuzumab ozogamicin-dose level 2
Pfizer
Leukemia
1 trial -
insulin detemir
Novo Nordisk A/S
Diabetes
2 trials -
insulin lispro injection, exenatide injection
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
intravenous NAC
CUMBERLAND PHARMACEUTICALS INC
Nephropathy
1 trial -
intravenous sufentanil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Analgesia, Patient-Controlled
1 trial -
intravenous tranexamic acid (TXA) infusion
The First People's Hospital of Lianyungang
Spontaneous Intracranial Hemorrhage
1 trial -
iodixanol
The First People's Hospital of Lianyungang
Kidney Failure, Chronic
1 trial -
iron and zinc combined
United Therapeutics Europe Ltd
Anemia
1 trial -
isoniazid, rifampin, pyrazinamide
Hospital Authority, Hong Kong
Hepatitis
1 trial -
ketamine
Cardiff Oncology
Healthy Volunteers
1 trial -
ketamine
United Therapeutics Europe Ltd
Acute Pain
1 trial -
lactate group:lactate acide clearance directed group; ScvO2 group:ScvO2 directed group;control group
Chinese University of Hong Kong
Shock, Septic
1 trial -
lactulose (Kristalose®)
CUMBERLAND PHARMACEUTICALS INC
Constipation
1 trial -
lamivudine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Compensated Chronic Hepatitis B
1 trial -
large protein molecule
HALOZYME THERAPEUTICS, INC.
Rheumatoid Arthritis
1 trial -
laronidase
BioMarin Pharmaceutical Australia Pty Ltd
Mucopolysaccharidosis I
3 trials -
lorlatinib
The First People's Hospital of Lianyungang
NSCLC
1 trial -
low-dose rivaroxaban
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atrial Fibrillation
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs